Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Dual Diagnosis|November 14, 2014
Use of synthetic cannabinoids in patients with psychotic disorders: case seriesAndreja Celofiga, Jure Koprivsek, Janez Klavz
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 25, 2008
Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypesVita Dolzan, Alessandro Serretti, Laura Mandelli, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2010
A population pharmacokinetic evaluation of the influence of CYP2D6 genotype on risperidone metabolism in patients with acute episode of schizophreniaIgor Locatelli, Matej Kastelic, Jure Koprivsek, et al.
Frontiers in Psychiatry|April 25, 2022
Effectiveness of De-Escalation in Reducing Aggression and Coercion in Acute Psychiatric Units. A Cluster Randomized StudyAndreja Celofiga, Blanka Kores Plesnicar, Jure Koprivsek, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 25, 2007
Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatmentVita Dolzan, Blanka Kores Plesnicar, Alessandro Serretti, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 12, 2010
MDR1 gene polymorphisms and response to acute risperidone treatmentMatej Kastelic, Jure Koprivsek, Blanka Kores Plesnicar, et al.
Pageof 1